Phase Separation & RNA Processing as Drivers of Cancer & Neurodegenerative Disease
In-Person Event
Feb 24 - 27, 2017
San Diego, California, USASpeakers
OVERVIEW
Phase Separation & RNA Processing as Drivers of Cancer & Neurodegenerative Disease is organized by Zing Conferences and would be held during Feb 24 - 27, 2017 at Rancho Bernardo Inn, San Diego, California, United States of America.
A significant challenge in clinical medicine, particularly in cancer and neurodegenerative disease, is the absence of pharmaceuticals that directly target the pathology. In cancer, well over 90% of mutations found in patient tumors are deemed ‘non-actionable’.
Many proteins with ‘non-actionable’ mutations are investigated by scientists who study RNA biology, in particular abnormalities in post-transcriptional RNA processing. Biophysicists and engineers have made great strides in understanding biological phase transitions and the role of intrinsically disordered protein (IDP) domains, which have been implicated in both diseases and often described as ‘non-actionable’. This conference seeks to bring together disease-focused medical scientists, RNA biologists, and biophysicists in a truly multidisciplinary environment.
The goals include :
• Have members of different disciplines become aware of recent advances and outstanding remaining questions in the fields of cancer, RNA, IDP, and phase transition biology.
• Address current challenges to overcoming barriers to the advancement of science and medicine in these fields and identify technical opportunities that meet these challenges.
• Develop individual enthusiasm to further explore multi-disciplinary research as a vehicle to advance understanding of human biology, public health, and scientific knowledge.
• Initiate collaborations across disciplines.
A significant challenge in clinical medicine, particularly in cancer and neurodegenerative disease, is the absence of pharmaceuticals that directly target the pathology. In cancer, well over 90% of mutations found in patient tumors are deemed ‘non-actionable’.
Many proteins with ‘non-actionable’ mutations are investigated by scientists who study RNA biology, in particular abnormalities in post-transcriptional RNA processing. Biophysicists and engineers have made great strides in understanding biological phase transitions and the role of intrinsically disordered protein (IDP) domains, which have been implicated in both diseases and often described as ‘non-actionable’. This conference seeks to bring together disease-focused medical scientists, RNA biologists, and biophysicists in a truly multidisciplinary environment.
The goals include :
• Have members of different disciplines become aware of recent advances and outstanding remaining questions in the fields of cancer, RNA, IDP, and phase transition biology.
• Address current challenges to overcoming barriers to the advancement of science and medicine in these fields and identify technical opportunities that meet these challenges.
• Develop individual enthusiasm to further explore multi-disciplinary research as a vehicle to advance understanding of human biology, public health, and scientific knowledge.
• Initiate collaborations across disciplines.
KEY DATES
24 Feb, 2017
Event Start Date
27 Feb, 2017
Event End Date
SPECIALITIES
NeurologyResearch and Clinical ResearchSUGGESTED HOTELS
CONFERENCE VENUE
Rancho Bernardo InnRELATED CONFERENCES & LIVE WEBINARS
Quick Links